Abstract

After comparing the morbidity patterns of COVID-19 infections, variations of oxytocin levels and some properties of the neurohormone oxytocin, the authors put forward their hypothesis that oxytocin might constitute a safe, inexpensive and readily available treatment for this disease.

Keywords

COVID-19; pandemic; treatment; oxytocin; immune system; inflammation

Published in

Clinical Neuropsychiatry
2020, Volume: 17, number: 3, pages: 192-195

SLU Authors

• Uvnäs-Moberg, Kerstin

  • Department of Applied Animal Science and Welfare, Swedish University of Agricultural Sciences
    

Sustainable Development Goals

SDG3 Ensure healthy lives and promote well-being for all at all ages


UKÄ Subject classification

Pharmacology and Toxicology


Publication identifier

DOI: https://doi.org/10.36131/CNEPUB20201703

Permanent link to this page (URI)

https://res.slu.se/id/publ/106969